{
     "PMID": "29174415",
     "OWN": "NLM",
     "STAT": "In-Process",
     "LR": "20180208",
     "IS": "1532-2785 (Electronic) 0143-4179 (Linking)",
     "VI": "67",
     "DP": "2018 Feb",
     "TI": "Neuroinflammation induced by amyloid beta25-35 modifies mucin-type O-glycosylation in the rat's hippocampus.",
     "PG": "56-62",
     "LID": "S0143-4179(17)30159-2 [pii] 10.1016/j.npep.2017.11.008 [doi]",
     "AB": "Amyloid-beta (Abeta) plays a relevant role in the neurodegenerative process of Alzheimer's disease (AD). The 25-35 peptide of amyloid-beta (Abeta25-35) induces the inflammatory response in brain experimental models. Mucin-type O-glycosylation has been associated with inflammation of brain tissues in AD, thus in this work, we aimed at identifying changes in the glycosylation profile generated by the injection of Abeta25-35 into the CA1 of the hippocampus of rats, using histochemistry with lectins. Our results indicate that 100muM Abeta25-35 induce increased recognition of the Amaranthus leucocarpus lectin (ALL) (specific for Galbeta1,3-GalNAcalpha1,0-Ser/Thr); whereas concanavalin A (Con A) (specific for alpha-Man) showed no differences among treated and control groups of rats. Jacalin and peanut agglutinin (Galbeta1,3GalNAcalpha1,0-Ser/Thr) showed no recognition of brain cells of control or treated rats. After 6-h treatment of the tissue with trypsin or with 200mM GalNAc, the interaction with ALL was inhibited. Immunohistochemistry showed positive anti-NeuN and ALL-recognition of neurons; however, anti-GFAP and anti-CD11b showed no co-localization with ALL. The ALL+ neurons revealed the presence of cytochrome C in the cytosol and active caspase 3 in the cytosol and nucleus. Administration of the interleukin-1 receptor antagonist (IL-1RA) to Abeta25-35-treated rats diminished neuroinflammation and ALL recognition. These results suggest a close relationship among over-expression of mucin-type O-glycosylation, the neuroinflammatory process, and neuronal death.",
     "CI": [
          "Copyright (c) 2017 Elsevier Ltd. All rights reserved."
     ],
     "FAU": [
          "Ramos-Martinez, Ivan",
          "Martinez-Loustalot, Pamela",
          "Lozano, Liliana",
          "Issad, Tarik",
          "Limon, Daniel",
          "Diaz, Alfonso",
          "Perez-Torres, Armando",
          "Guevara, Jorge",
          "Zenteno, Edgar"
     ],
     "AU": [
          "Ramos-Martinez I",
          "Martinez-Loustalot P",
          "Lozano L",
          "Issad T",
          "Limon D",
          "Diaz A",
          "Perez-Torres A",
          "Guevara J",
          "Zenteno E"
     ],
     "AD": "Departamento de Bioquimica, Facultad de Medicina, Universidad Nacional Autonoma de Mexico, 04510, Mexico; Posgrado en Ciencias Biomedicas, Universidad Nacional Autonoma de Mexico, Av. Ciudad Universitaria 3000, C.P. 04510, Mexico. Departamento de Bioquimica, Facultad de Medicina, Universidad Nacional Autonoma de Mexico, 04510, Mexico. Departamento de Bioquimica, Facultad de Medicina, Universidad Nacional Autonoma de Mexico, 04510, Mexico. CNRS, Departement d'Endocrinologie, Metabolisme et Cancer, Institut Cochin, 75014 Paris, France. Laboratorio de Neurofarmacologia, Facultad de Ciencias Quimicas, Benemerita Universidad Autonoma de Puebla, Puebla, Mexico. Departamento de Farmacia, Facultad de Ciencias Quimicas, Benemerita Universidad Autonoma de Puebla, Puebla, Mexico. Departamento de Biologia Celular y Tisular, Facultad de Medicina, Universidad Nacional Autonoma de Mexico, 04510, Mexico. Departamento de Bioquimica, Facultad de Medicina, Universidad Nacional Autonoma de Mexico, 04510, Mexico. Departamento de Bioquimica, Facultad de Medicina, Universidad Nacional Autonoma de Mexico, 04510, Mexico. Electronic address: ezenteno@unam.mx.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article"
     ],
     "DEP": "20171121",
     "PL": "Netherlands",
     "TA": "Neuropeptides",
     "JT": "Neuropeptides",
     "JID": "8103156",
     "OTO": [
          "NOTNLM"
     ],
     "OT": [
          "Alzheimer's disease",
          "Apoptosis",
          "Lectin",
          "Mucin-type glycosylation",
          "Neuroinflammation"
     ],
     "EDAT": "2017/11/28 06:00",
     "MHDA": "2017/11/28 06:00",
     "CRDT": [
          "2017/11/28 06:00"
     ],
     "PHST": [
          "2017/05/05 00:00 [received]",
          "2017/11/17 00:00 [revised]",
          "2017/11/17 00:00 [accepted]",
          "2017/11/28 06:00 [pubmed]",
          "2017/11/28 06:00 [medline]",
          "2017/11/28 06:00 [entrez]"
     ],
     "AID": [
          "S0143-4179(17)30159-2 [pii]",
          "10.1016/j.npep.2017.11.008 [doi]"
     ],
     "PST": "ppublish",
     "SO": "Neuropeptides. 2018 Feb;67:56-62. doi: 10.1016/j.npep.2017.11.008. Epub 2017 Nov 21.",
     "term": "hippocampus"
}